» Articles » PMID: 31858162

[Early Recognition and Prevention of Schizophrenia and Other Psychoses]

Overview
Journal Nervenarzt
Specialty Neurology
Date 2019 Dec 21
PMID 31858162
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The last two decades of clinical research have clearly demonstrated the comprehensive benefits of the early recognition and treatment of psychotic disorders. The attenuated and transient positive symptoms according to the ultrahigh risk criteria and the basic symptom criterion "Cognitive disturbances" are the main approaches for an indicated prevention. They have recently been recommended as criteria for a clinical high-risk (CHR) state of psychosis by the European Psychiatric Association (EPA) and, following these, in the German S3 guidelines for the treatment of schizophrenia by the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN); however, the efficacy of early treatment of patients with a CHR for psychoses critically depends on the development of prognostic instruments, which enable healthcare professionals to reliably identify these patients based on the individual objective risk profiles. An important goal is the treatment of functional deficits, which can be identified by an individual risk profile. The treatment of existing comorbid mental disorders, psychosocial problems and the prevention of potential future disorders also characterizes the recommendations of the EPA and DGPPN for early treatment, which favor psychotherapeutic, especially cognitive behavioral interventions over pharmacological treatment. The close interdisciplinary cross-sectoral cooperation between the disciplines of child and adolescent psychiatry, and adult psychiatry is of outstanding importance in this context.

Citing Articles

A qualitative of stable symptomatology for patients with schizophrenia: do they have adequate post-discharge rehabilitative resources?.

Sun X, Zhang X, Liu L, Zhang L, Zhan T, Chen Y Schizophrenia (Heidelb). 2023; 9(1):29.

PMID: 37156777 PMC: 10167338. DOI: 10.1038/s41537-023-00358-9.


The positive dimension of schizotypy is associated with a reduced attenuation and precision of self-generated touch.

Asimakidou E, Job X, Kilteni K Schizophrenia (Heidelb). 2022; 8(1):57.

PMID: 35854009 PMC: 9261081. DOI: 10.1038/s41537-022-00264-6.


[Cohort studies in child and adolescent psychiatry].

Holz N, Nees F, Meyer-Lindenberg A, Tost H, Holling H, Keil T Nervenarzt. 2020; 92(3):208-218.

PMID: 33112964 PMC: 7592144. DOI: 10.1007/s00115-020-01018-4.

References
1.
Ding Y, Ou Y, Pan P, Shan X, Chen J, Liu F . Brain structural abnormalities as potential markers for detecting individuals with ultra-high risk for psychosis: A systematic review and meta-analysis. Schizophr Res. 2019; 209:22-31. DOI: 10.1016/j.schres.2019.05.015. View

2.
Schmidt A, Cappucciati M, Radua J, Rutigliano G, Rocchetti M, DellOsso L . Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation. Schizophr Bull. 2016; 43(2):375-388. PMC: 5605272. DOI: 10.1093/schbul/sbw098. View

3.
Schaffner N, Schimmelmann B, Niedersteberg A, Schultze-Lutter F . [Pathways-to-Care for First-Episode psychotic patients--an overview of international studies]. Fortschr Neurol Psychiatr. 2011; 80(2):72-8. DOI: 10.1055/s-0031-1273428. View

4.
Schultze-Lutter F, Michel C, Schmidt S, Schimmelmann B, Maric N, Salokangas R . EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 2015; 30(3):405-16. DOI: 10.1016/j.eurpsy.2015.01.010. View

5.
Karow A, Bock T, Naber D, Lowe B, Schulte-Markwort M, Schafer I . [Mental health of children, adolescents and young adults--part 2: burden of illness, deficits of the German health care system and efficacy and effectiveness of early intervention services]. Fortschr Neurol Psychiatr. 2013; 81(11):628-38. DOI: 10.1055/s-0033-1355840. View